$12.97+0.9%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed October 26, 2026
Company outlook: revenue of $55M to $75M for Fiscal Q4 2026 — down 13.4% on a year earlier ($75.1M)
Just reported
From Medifast Inc.'s results release of October 26, 2026; its quarterly report has since been filed.
Actual
$72M
-19% y/y
-5.7% q/q
Guided
$70M
midpoint
Actual
-$1.57
Guided
—
No guide given
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $72M | $89.4M | -19.42% |
| Profit | -$17.5M | -$2.3M | -674.48% |
| Profit per share | -$1.57 | -$0.21 | -647.62% |
| Free Cash Flow | $2.9M | $10.8M | -73.32% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Medifast Inc. has no earnings call transcript available.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
The quote and the company description come from Medifast Inc.’s Item 2.02 8-K filed October 26, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Actual
-$19.4M
Guided
—
No guide given
Q4 2026
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.